Skip to content

Clinical trials

Phase 1 Glioblastoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1 Country / region: Australia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20111
20123
20142
20151
20172
20181
20192
20203
20221
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting5
Not yet recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Olivia Newton-John Cancer Research Institute3
Amgen2
AbbVie1
Cellectar Biosciences, Inc.1
Charlotte Lemech1
Eli Lilly and Company1
Hoffmann-La Roche1
NYU Langone Health1
Nationwide Children's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma22
Glioma8
Astrocytoma5
Brain Neoplasms4
Breast Neoplasms3
Cholangiocarcinoma3
Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Central Nervous System Neoplasms2
Colorectal Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.